Search results
Results From The WOW.Com Content Network
Foundation Medicine was founded in Cambridge, Massachusetts. [3] The company was conceived after Broad Institute researchers Levi Garraway and Matthew Meyerson published a 2007 paper detailing a method for large-panel testing of 238 DNA mutations. [4] Foundation Medicine launched in 2010 with a $25 million Series A financing led by Third Rock ...
In December 2017, Michael Pellini, the former CEO and standing Chairman of Foundation Medicine joined S32 as a Managing Partner. [13] In early 2019, Section 32 announced that it had raised nearly $200M for a second fund. [14] In November 2019, Steve Kafka, joined Section 32 as a Managing Partner.
Foundation Medicine Prices Initial Public Offering of Common Stock CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the pricing of its initial public offering of ...
Martine Aliana Rothblatt is an American lawyer, author, and entrepreneur. Rothblatt graduated from University of California, Los Angeles with J.D. and M.B.A. degrees in 1981, then began to work in Washington, D.C., first in the field of communications satellite law, then in bioethics and biomedicine. [3]
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
For premium support please call: 800-290-4726 more ways to reach us
2011 – Covidien announced plans to spin off Mallinckrodt Pharmaceuticals, [64] [65] and Mallinckrodt Plc was separated on June 28, 2013, trading on the ticker MNK from July 1, 2013. [2] 2012 – Mallinckrodt announced acquisition of CNS Therapeutics for $100 million [66]
Matthew Langer Meyerson (born June 4, 1963) is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. [1] He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, [2] and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.